QC
KURA icon

Quadrature Capital’s Kura Oncology KURA Stock Holding History

Quadrature Capital’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$611K Buy
55,714
+43,487
+356% +$410K 0.01% 941
2026
Q1 		$99.4K Buy
+12,227
New +$105K ﹤0.01% 1226
2025
Q4 		– Sell
-13,331
Closed -$118K – 1485
2025
Q3 		$118K Buy
+13,331
New +$95K ﹤0.01% 857

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Quadrature Capital's KURA Position: Q2 2026 in Review

Quadrature Capital increased its Kura Oncology (KURA) stake by 356% in Q2 2026, buying an estimated $410K and bringing the position to 55,714 shares worth $611K. The position accounts for 0.01% of the portfolio, ranked #941.

Quadrature Capital first reported a position in KURA in Q3 2025 and has held it in 3 quarters since. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Quadrature Capital held 55,714 shares of Kura Oncology worth $611K as of Q2 2026.
  • Quadrature Capital bought 43,487 Kura Oncology shares in Q2 2026, an estimated $410K.
  • Kura Oncology made up 0.01% of Quadrature Capital's portfolio in Q2 2026, its #941 holding.
  • Quadrature Capital first reported a position in Kura Oncology in Q3 2025 and has held it in 3 quarters since.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.